Cite
MLA Citation
R N Maini et al.. “Anti-tumour necrosis factor specific antibody (infliximab) treatment provides insights into the pathophysiology of rheumatoid arthritis.” Annals of the rheumatic diseases, vol. 58, n.d., pp. I56–I60. http://access.bl.uk/ark:/81055/vdc_100148627707.0x00005b